Synthetic Biology Patent Applications Expected to Present New Challenges
06 June 2008
Foley Partner Mark Waxman and Patent Agent Vid Mohan-Ram recently authored an article titled, “Synthetic Biology Patent Applications Expected to Present New Challenges,” in the June 6, 2008 issue of Life Sciences Law & Industry Report. The article addresses the U.S. patent applications that expressly focus on synthetic biology, and how the U.S. Patent & Trademark Office is handling and examining them.
Reproduced with permission from Life Sciences Law & Industry Report, Vol. 2, No. 12 (June 6, 2008) pp. 473-474. Copyright 2008 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
Related Insights
23 December 2024
Labor & Employment Law Perspectives
Regulating Artificial Intelligence in Employment Decision-Making: What’s on the Horizon for 2025
Share on TwitterShare by EmailShareBack to topEmployment law in 2024 could aptly be summarized as the “Year of Artificial Intelligence Legislation.
23 December 2024
Injunction Stayed: Corporate Transparency Act Enforcement Resumes
The U.S. Department of Justice scored a victory in ongoing litigation over the constitutionality of the Corporate Transparency Act (CTA) when the Fifth Circuit Court of Appeals stayed the nationwide preliminary injunction issued earlier this month by a federal district court in Texas.
23 December 2024
Health Care Law Today
Medicare Telehealth Flexibilities Get a Three-Month Lifeline
Share on TwitterShare by EmailShareBack to topAfter much uncertainty, Congress has extended many Medicare telehealth flexibilities through March 31, 2025, in its end-of-year appropriations bill.